Drexel University College of Medicine

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1848-01-01

Employees: -

Market Cap: -

Website: http://www.drexelmed.edu

Clinical Trials

Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing

Phase 1

Terminated

Conditions: Pain

Interventions: Drug: lidocaine
Drug: Placebo

First Posted Date: 2017-04-17

Last Posted Date: 2017-05-09

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 19

Registration Number: NCT03117166

Locations: 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Radiation: Radiotherapy
Drug: Leucovorin
Biological: Cetuximab
Drug: Filgrastim
Drug: Erythropoetin
Drug: Cisplatin
Drug: Fluorouracil
Drug: Docetaxel

First Posted Date: 2011-11-08

Last Posted Date: 2017-05-09

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 1

Registration Number: NCT01467115

Locations: 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias

Not Applicable

Withdrawn

Conditions: Cardiac Arrhythmia

Interventions: Device: Dataq Instruments DI-158

First Posted Date: 2011-05-25

Last Posted Date: 2013-06-14

Lead Sponsor: Drexel University College of Medicine

Registration Number: NCT01359683

Locations: 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Phase 4

Completed

Conditions: Epilepsy

Interventions: Drug: Levetiracetam

First Posted Date: 2011-03-18

Last Posted Date: 2018-10-12

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 24

Registration Number: NCT01318408

Locations: 🇺🇸
Drexel University College of Medicine, Dept of Neurology, Philadelphia, Pennsylvania, United States

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

Phase 2

Terminated

Conditions: End Stage Renal Disease

Interventions: Drug: basiliximab

First Posted Date: 2009-06-26

Last Posted Date: 2015-02-10

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 5

Registration Number: NCT00928811

Locations: 🇺🇸
Drexel University College of Medicine, Philadelphia, Pennsylvania, United States

EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)

Completed

Conditions: Amyotrophic Lateral Sclerosis
Neurodegenerative Disease
Motor Neuron Disease

First Posted Date: 2008-07-18

Last Posted Date: 2017-03-30

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 102

Registration Number: NCT00718458

Locations: 🇺🇸
MDA/ALS Center of Hope, Philadelphia, Pennsylvania, United States

Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).

Terminated

Conditions: Amyotrophic Lateral Sclerosis
Neurodegenerative Disease
Motor Neuron Disease

First Posted Date: 2008-07-18

Last Posted Date: 2013-03-05

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 10

Registration Number: NCT00718003

Locations: 🇺🇸
MDA/ALS Center of Hope, Philadelphia, Pennsylvania, United States

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

Terminated

Conditions: Amyotrophic Lateral Sclerosis
Neurodegenerative Disease
Motor Neuron Disease

First Posted Date: 2008-07-18

Last Posted Date: 2013-03-05

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 1

Registration Number: NCT00718016

Locations: 🇺🇸
MDA/ALS Center of Hope, Philadelphia, Pennsylvania, United States

Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology

Terminated

Conditions: Neurodegenerative Disease
Amyotrophic Lateral Sclerosis
Motor Neuron Disease

First Posted Date: 2008-07-18

Last Posted Date: 2013-03-05

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 5

Registration Number: NCT00718107

Locations: 🇺🇸
MDA/ALS Center of Hope, Philadelphia, Pennsylvania, United States

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

Completed

Conditions: Neurodegenerative Disease
Amyotrophic Lateral Sclerosis
Motor Neuron Disease

First Posted Date: 2008-07-18

Last Posted Date: 2013-03-05

Lead Sponsor: Drexel University College of Medicine

Target Recruit Count: 25

Registration Number: NCT00718497

Locations: 🇺🇸
MDA/ALS Center of Hope, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy